Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 36 out of 100. Health systems and care delivery

Topic: Amyloid, tau and blood-test diagnosis

Pre-diagnosis of common dementia conditions such as Alzheimer’s disease (AD) in the initial stages is crucial to help in early intervention, treatment plan design, disease management, and for providing quicker healthcare access. Current assessments are often stressful, invasive, and unavailable in most countries worldwide. In addition, many cognitive assessments are time-consuming and rarely cover all cognitive domains involved in dementia diagnosis. Therefore, the design and implementation of an intelligent method for dementia signs of progression from a few cognitive items in a manner that is accessible, easy, affordable, quick to perform, and does not require special and expensive resources is desirable. This paper investigates the issue of dementia progression by proposing a new classification algorithm called Alzheimer’s Disease Class Rules (AD-CR). The AD-CR algorithm learns models from the distinctive feature subsets that contain rules with low overlapping among their cognitive items yet are easily interpreted by clinicians during clinical assessment. An empirical evaluation of the Disease Neuroimaging Initiative data repository (ADNI) datasets shows that the AD-CR algorithm offers good performance (accuracy, sensitivity, etc.) when compared with other machine learning algorithms. The AD-CR algorithm was superior in comparison to the other algorithms overall since it reached a performance above 92%, 92.38% accuracy, 91.30% sensitivity, and 93.50% specificity when processing data subsets with cognitive and demographic attributes.

Key findings

Why it matters

This study developed a classification algorithm using cognitive and demographic data that reached above 92% accuracy in distinguishing dementia stages. It is a computer-based assessment method and does not test any treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 36/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 36 of 100.36 of 100 points earned64 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Applied Sciences)
Journal's citation record 2 / 4 Applied Sciences: journal h-index 230 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 6 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.2 citations a year over 5 year(s) since 2023
Impact for its field and year 2 / 6 Cited 1.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author David Peebles: h-index 21 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Huddersfield: institution h-index 265 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 36 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Thabtah, F., & Peebles, D. (2023). Assessment for Alzheimer’s Disease Advancement Using Classification Models with Rules. Applied Sciences. https://doi.org/10.3390/app132212152

Vancouver

Thabtah F, Peebles D. Assessment for Alzheimer’s Disease Advancement Using Classification Models with Rules. Applied Sciences. 2023. doi:10.3390/app132212152.

BibTeX

@article{thabtah2023-e90c057a,
  author  = {Thabtah, Fadi and Peebles, David},
  title   = {{Assessment for Alzheimer’s Disease Advancement Using Classification Models with Rules}},
  journal = {Applied Sciences},
  year    = {2023},
  doi     = {10.3390/app132212152},
  url     = {https://doi.org/10.3390/app132212152}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Health systems and care delivery

Also in Health systems and care delivery

172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →